Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FWGJ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,547
Award facts
- Contract value 100% obligated
- $13,546.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,546.76 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml quantities. This is a firm fixed-price delivery order with an ultimate completion date of December 8, 2025, issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC enables it to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. This particular delivery order for Ozempic, a diabetes medication, exemplifies the company's role in fulfilling specialized pharmaceutical needs within the federal medical supply chain. All of AmerisourceBergen's reviewed DLA contracts have been competitively awarded on a non-set-aside basis, demonstrating its capability to meet stringent federal procurement requirements.
Quick answers
Who was awarded contract SPE2DR26FWGJ4?
SPE2DR26FWGJ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FWGJ4 worth?
The government has obligated $13,547 on SPE2DR26FWGJ4.
Is contract SPE2DR26FWGJ4 an order under another contract?
Yes. SPE2DR26FWGJ4 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWGJ4 competed?
The extent of competition for SPE2DR26FWGJ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award